Slc51b Rat (-)-epigallocatechin 3-gallate multiple interactions ISO SLC51B (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of SLC51B mRNA] and epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51B mRNA] CTD PMID:22178739 Slc51b Rat (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Ethinyl Estradiol] results in increased expression of SLC51B mRNA CTD PMID:23146761 Slc51b Rat (R)-pantothenic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Pantothenic Acid results in increased expression of SLC51B mRNA CTD PMID:19397697 Slc51b Rat 1,1-dichloroethene decreases expression ISO Slc51b (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC51B mRNA CTD PMID:26682919 Slc51b Rat 1,2-dimethylhydrazine decreases expression ISO Slc51b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC51B mRNA CTD PMID:22206623 Slc51b Rat 1-naphthyl isothiocyanate increases expression ISO Slc51b (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA CTD PMID:19407337 more ... Slc51b Rat 1-naphthyl isothiocyanate multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] more ... CTD PMID:28549656 more ... Slc51b Rat 1-naphthyl isothiocyanate multiple interactions ISO SLC51B (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat 17alpha-ethynylestradiol multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Ethinyl Estradiol] results in increased expression of SLC51B mRNA CTD PMID:23146761 Slc51b Rat 17alpha-ethynylestradiol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat 17beta-estradiol increases expression ISO SLC51B (Homo sapiens) 6480464 Estradiol results in increased expression of SLC51B mRNA CTD PMID:20106945 Slc51b Rat 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO SLC51B (Homo sapiens) 6480464 2 more ... CTD PMID:20638727 Slc51b Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Slc51b Rat 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Slc51b (Mus musculus) 6480464 ESR1 gene mutant form inhibits the reaction [2 more ... CTD PMID:29112739 Slc51b Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Slc51b (Mus musculus) 6480464 2 more ... CTD PMID:29112739 Slc51b Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLC51B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA CTD PMID:20106945 and PMID:21632981 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC51B mRNA CTD PMID:33387578 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc51b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA CTD PMID:29452137 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc51b (Mus musculus) 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA] CTD PMID:29452137 Slc51b Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc51b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC51B mRNA CTD PMID:26377647 Slc51b Rat 3,3',5-triiodo-L-thyronine increases expression ISO SLC51B (Homo sapiens) 6480464 Triiodothyronine results in increased expression of SLC51B mRNA CTD PMID:21815645 Slc51b Rat 3,3',5-triiodo-L-thyronine multiple interactions ISO SLC51B (Homo sapiens) 6480464 (4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3 and 5-dimethylphenoxy)acetic acid inhibits the reaction [Triiodothyronine results in increased expression of SLC51B mRNA] CTD PMID:21815645 Slc51b Rat 4,4'-sulfonyldiphenol decreases expression ISO Slc51b (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC51B mRNA CTD PMID:33297965 Slc51b Rat 4,4'-sulfonyldiphenol increases methylation ISO Slc51b (Mus musculus) 6480464 bisphenol S results in increased methylation of SLC51B promoter CTD PMID:33297965 Slc51b Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC51B mRNA CTD PMID:24780913 Slc51b Rat 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO Slc51b (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of SLC51B mRNA CTD PMID:33749747 Slc51b Rat aflatoxin B1 increases expression ISO SLC51B (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SLC51B mRNA CTD PMID:21632981 and PMID:21641981 Slc51b Rat allocholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 allocholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:37968239 Slc51b Rat allopurinol multiple interactions ISO Slc51b (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of SLC51B mRNA CTD PMID:33749747 Slc51b Rat aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of SLC51B mRNA CTD PMID:23912714 Slc51b Rat arsane decreases expression ISO SLC51B (Homo sapiens) 6480464 Arsenic results in decreased expression of SLC51B mRNA CTD PMID:36861143 Slc51b Rat arsenic atom decreases expression ISO SLC51B (Homo sapiens) 6480464 Arsenic results in decreased expression of SLC51B mRNA CTD PMID:36861143 Slc51b Rat atazanavir sulfate multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:32152650 Slc51b Rat Azoxymethane multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B mRNA CTD PMID:29950665 Slc51b Rat aztreonam decreases expression ISO Slc51b (Mus musculus) 6480464 Aztreonam results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat benzo[a]pyrene increases expression ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC51B mRNA CTD PMID:21632981 Slc51b Rat benzo[a]pyrene decreases expression ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC51B mRNA CTD PMID:32234424 Slc51b Rat benzo[a]pyrene increases methylation ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC51B exon and Benzo(a)pyrene results in increased methylation of SLC51B promoter CTD PMID:27901495 Slc51b Rat benzo[a]pyrene affects methylation ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC51B 5' UTR CTD PMID:27901495 Slc51b Rat benzo[a]pyrene diol epoxide I increases expression ISO SLC51B (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Slc51b Rat beta-hexachlorocyclohexane decreases expression ISO Slc51b (Mus musculus) 6480464 beta-hexachlorocyclohexane results in decreased expression of SLC51B mRNA CTD PMID:28392238 Slc51b Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC51B mRNA CTD PMID:25181051 Slc51b Rat bisphenol A affects expression ISO SLC51B (Homo sapiens) 6480464 bisphenol A affects the expression of SLC51B mRNA CTD PMID:30903817 Slc51b Rat bosentan increases expression ISO SLC51B (Homo sapiens) 6480464 Bosentan results in increased expression of SLC51B mRNA CTD PMID:29761207 Slc51b Rat budesonide multiple interactions EXP 6480464 [Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat budesonide increases expression ISO SLC51B (Homo sapiens) 6480464 Budesonide results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat caffeine increases phosphorylation ISO SLC51B (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of SLC51B protein CTD PMID:35688186 Slc51b Rat calcitriol decreases expression ISO SLC51B (Homo sapiens) 6480464 Calcitriol results in decreased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat calcitriol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Calcitriol co-treated with Chenodeoxycholic Acid] results in decreased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat carbon nanotube increases expression ISO Slc51b (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of SLC51B mRNA CTD PMID:25620056 Slc51b Rat cefalotin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat CGP 52608 multiple interactions ISO SLC51B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC51B gene] CTD PMID:28238834 Slc51b Rat chenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:16423920 more ... Slc51b Rat chenodeoxycholic acid multiple interactions EXP 6480464 [Chenodeoxycholic Acid binds to NR1H4 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat chenodeoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Chenodeoxycholic Acid results in increased expression of SLC51B mRNA and Chenodeoxycholic Acid results in increased expression of SLC51B protein CTD PMID:16423920 more ... Slc51b Rat chlorpromazine multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat cholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Cholic Acid results in increased expression of SLC51B mRNA CTD PMID:25055961 Slc51b Rat cholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Cholic Acid results in increased expression of SLC51B mRNA CTD PMID:22961653 and PMID:25582706 Slc51b Rat cholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in increased expression of SLC51B mRNA CTD PMID:22540009 Slc51b Rat choline multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC51B mRNA CTD PMID:20938992 Slc51b Rat chromium(6+) affects expression ISO Slc51b (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC51B mRNA CTD PMID:28472532 Slc51b Rat ciprofloxacin decreases expression ISO Slc51b (Mus musculus) 6480464 Ciprofloxacin results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat cisplatin multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC51B mRNA CTD PMID:27392435 Slc51b Rat cisplatin increases expression ISO SLC51B (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC51B mRNA CTD PMID:27392435 and PMID:38498338 Slc51b Rat clofibrate decreases expression ISO Slc51b (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC51B mRNA CTD PMID:28973556 Slc51b Rat cyclosporin A increases expression ISO SLC51B (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC51B mRNA CTD PMID:20106945 more ... Slc51b Rat cyclosporin A decreases expression ISO SLC51B (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC51B mRNA CTD PMID:25562108 more ... Slc51b Rat cyclosporin A multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of SLC51B mRNA and [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:27344345 and PMID:32152650 Slc51b Rat DDE decreases expression ISO Slc51b (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC51B mRNA CTD PMID:28392238 Slc51b Rat deoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Deoxycholic Acid results in increased expression of SLC51B and Deoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:22268002 and PMID:25055961 Slc51b Rat deoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 Slc51b Rat deoxycholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Deoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:21914718 and PMID:25582706 Slc51b Rat deoxycholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in increased expression of SLC51B mRNA] CTD PMID:21914718 Slc51b Rat dexamethasone multiple interactions EXP 6480464 [Dexamethasone binds to NR3C1 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat dexamethasone increases expression ISO SLC51B (Homo sapiens) 6480464 Dexamethasone results in increased expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat dextran sulfate multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B mRNA CTD PMID:29950665 Slc51b Rat dibenzofurans decreases expression ISO Slc51b (Mus musculus) 6480464 Dibenzofurans results in decreased expression of SLC51B mRNA CTD PMID:34254344 Slc51b Rat dioxygen increases expression ISO SLC51B (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC51B mRNA CTD PMID:24703425 Slc51b Rat epoxiconazole decreases expression ISO Slc51b (Mus musculus) 6480464 epoxiconazole results in decreased expression of SLC51B mRNA CTD PMID:35436446 Slc51b Rat ethyl methanesulfonate decreases expression ISO SLC51B (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC51B mRNA CTD PMID:23649840 Slc51b Rat fidaxomicin multiple interactions ISO SLC51B (Homo sapiens) 6480464 Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake of Glycochenodeoxycholic Acid] more ... CTD PMID:32294204 Slc51b Rat fipronil increases expression ISO SLC51B (Homo sapiens) 6480464 fipronil results in increased expression of SLC51B mRNA CTD PMID:27091632 Slc51b Rat fipronil multiple interactions ISO SLC51B (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of SLC51B mRNA CTD PMID:27091632 Slc51b Rat folic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC51B mRNA CTD PMID:20938992 Slc51b Rat folic acid decreases expression ISO Slc51b (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC51B mRNA CTD PMID:25629700 Slc51b Rat glycochenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 and PMID:32294204 Slc51b Rat glycocholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 and PMID:32294204 Slc51b Rat glycodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 Slc51b Rat glycyrrhetinate multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 Slc51b Rat glycyrrhetinic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 Slc51b Rat glycyrrhizinic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 Slc51b Rat GW 4064 multiple interactions ISO Slc51b (Mus musculus) 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in increased expression of SLC51B mRNA more ... CTD PMID:20091679 more ... Slc51b Rat GW 4064 increases expression ISO SLC51B (Homo sapiens) 6480464 GW 4064 results in increased expression of SLC51B mRNA CTD PMID:22178739 Slc51b Rat GW 4064 increases expression ISO Slc51b (Mus musculus) 6480464 GW 4064 results in increased expression of SLC51B mRNA CTD PMID:23178280 more ... Slc51b Rat GW 4064 multiple interactions ISO SLC51B (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51B mRNA] CTD PMID:22178739 Slc51b Rat hydrogen peroxide affects expression ISO SLC51B (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC51B mRNA CTD PMID:20044591 Slc51b Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC51B mRNA CTD PMID:21396975 Slc51b Rat L-methionine multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC51B mRNA CTD PMID:20938992 Slc51b Rat lead(0) affects methylation ISO SLC51B (Homo sapiens) 6480464 Lead affects the methylation of SLC51B gene CTD PMID:31636367 Slc51b Rat leflunomide increases expression ISO SLC51B (Homo sapiens) 6480464 leflunomide results in increased expression of SLC51B mRNA CTD PMID:28988120 Slc51b Rat lithocholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Lithocholic Acid results in increased expression of SLC51B mRNA CTD PMID:19562681 and PMID:25055961 Slc51b Rat lithocholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Lithocholic Acid results in increased expression of SLC51B mRNA CTD PMID:17256725 and PMID:23034213 Slc51b Rat lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid binds to VDR protein] which affects the expression of SLC51B mRNA CTD PMID:19562681 Slc51b Rat lithocholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 NR1H3 protein inhibits the reaction [Lithocholic Acid results in increased expression of SLC51B mRNA] and SMAD3 protein promotes the reaction [Lithocholic Acid results in increased expression of SLC51B mRNA] CTD PMID:17256725 and PMID:23034213 Slc51b Rat manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC51B mRNA CTD PMID:28801915 Slc51b Rat mercury dichloride decreases expression ISO Slc51b (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 Slc51b Rat methyl methanesulfonate decreases expression ISO SLC51B (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC51B mRNA CTD PMID:23649840 Slc51b Rat methylmercury chloride decreases expression ISO Slc51b (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 Slc51b Rat methyltestosterone multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 Slc51b Rat metronidazole decreases expression ISO Slc51b (Mus musculus) 6480464 Metronidazole results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat N,N-diethyl-m-toluamide multiple interactions ISO SLC51B (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of SLC51B mRNA CTD PMID:27091632 Slc51b Rat N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC51B mRNA CTD PMID:28801915 Slc51b Rat nefazodone multiple interactions ISO SLC51B (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:32152650 Slc51b Rat neomycin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 Slc51b Rat obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:27255380 Slc51b Rat obeticholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:27939613 Slc51b Rat obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA] CTD PMID:27255380 Slc51b Rat obeticholic acid increases expression ISO Slc51b (Mus musculus) 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:26655953 Slc51b Rat ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of SLC51B mRNA CTD PMID:30449730 Slc51b Rat oleanolic acid increases expression ISO Slc51b (Mus musculus) 6480464 Oleanolic Acid results in increased expression of SLC51B mRNA and Oleanolic Acid results in increased expression of SLC51B protein CTD PMID:23948738 Slc51b Rat PCB138 multiple interactions ISO Slc51b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Slc51b Rat perfluorobutanesulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorobutanesulfonic acid CTD PMID:26001962 Slc51b Rat perfluorohexanesulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorohexanesulfonic acid CTD PMID:26001962 Slc51b Rat perfluorooctane-1-sulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorooctane sulfonic acid CTD PMID:26001962 Slc51b Rat perfluorooctane-1-sulfonic acid increases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of SLC51B mRNA CTD PMID:32253466 Slc51b Rat perfluorooctanoic acid increases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SLC51B mRNA CTD PMID:32253466 Slc51b Rat phenethyl caffeate multiple interactions ISO Slc51b (Mus musculus) 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51B mRNA and GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51B mRNA] CTD PMID:28223344 Slc51b Rat phenobarbital increases expression ISO SLC51B (Homo sapiens) 6480464 Phenobarbital results in increased expression of SLC51B mRNA and Phenobarbital results in increased expression of SLC51B protein CTD PMID:19084549 and PMID:35881160 Slc51b Rat pirinixic acid increases expression ISO Slc51b (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC51B mRNA CTD PMID:20813756 Slc51b Rat pirinixic acid decreases expression ISO Slc51b (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC51B mRNA CTD PMID:23811191 Slc51b Rat pirinixic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC51B mRNA CTD PMID:19710929 Slc51b Rat pirinixic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC51B mRNA CTD PMID:19710929 Slc51b Rat prothioconazole decreases expression ISO Slc51b (Mus musculus) 6480464 prothioconazole results in decreased expression of SLC51B mRNA CTD PMID:36007749 Slc51b Rat Prothioconazole-desthio decreases expression ISO Slc51b (Mus musculus) 6480464 prothioconazole-desthio results in decreased expression of SLC51B mRNA CTD PMID:36007749 Slc51b Rat pyrazinecarboxamide multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA] CTD PMID:27255380 Slc51b Rat pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLC51B mRNA and Pyrazinamide results in decreased expression of SLC51B protein CTD PMID:27255380 Slc51b Rat quercetin decreases expression ISO SLC51B (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC51B mRNA CTD PMID:21632981 Slc51b Rat resorcinol decreases expression ISO SLC51B (Homo sapiens) 6480464 resorcinol results in decreased expression of SLC51B mRNA CTD PMID:22623647 Slc51b Rat resveratrol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC51B mRNA CTD PMID:23557933 Slc51b Rat rifampicin increases expression ISO SLC51B (Homo sapiens) 6480464 Rifampin results in increased expression of SLC51B mRNA CTD PMID:27199754 Slc51b Rat serpentine asbestos increases expression ISO SLC51B (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of SLC51B mRNA CTD PMID:21148743 Slc51b Rat silicon dioxide decreases expression ISO SLC51B (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SLC51B mRNA CTD PMID:25895662 Slc51b Rat sodium arsenite decreases expression ISO SLC51B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC51B mRNA CTD PMID:29301061 Slc51b Rat sodium arsenite decreases expression ISO Slc51b (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC51B mRNA CTD PMID:37682722 Slc51b Rat sodium arsenite increases expression ISO SLC51B (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC51B mRNA CTD PMID:38568856 Slc51b Rat streptozocin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of SLC51B mRNA CTD PMID:29382564 Slc51b Rat taurochenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurochenodeoxycholic Acid more ... CTD PMID:32294204 Slc51b Rat taurocholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid and Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid] CTD PMID:32294204 Slc51b Rat tauroursodeoxycholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of SLC51B protein CTD PMID:36787806 Slc51b Rat tetrachloromethane decreases expression ISO Slc51b (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC51B mRNA CTD PMID:31919559 Slc51b Rat titanium dioxide multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B mRNA CTD PMID:29950665 Slc51b Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC51B mRNA CTD PMID:33387578 Slc51b Rat triclosan decreases expression ISO SLC51B (Homo sapiens) 6480464 Triclosan results in decreased expression of SLC51B mRNA CTD PMID:30510588 Slc51b Rat triclosan increases expression ISO SLC51B (Homo sapiens) 6480464 Triclosan results in increased expression of SLC51B mRNA CTD PMID:34681664 Slc51b Rat tris(2-butoxyethyl) phosphate affects expression ISO SLC51B (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC51B mRNA CTD PMID:29024780 Slc51b Rat ursodeoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Ursodeoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:25055961 Slc51b Rat ursodeoxycholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Ursodeoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:25582706 Slc51b Rat valproic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC51B mRNA CTD PMID:29154799